Medifast (MED) Competitors $13.16 +0.10 (+0.74%) Closing price 03:59 PM EasternExtended Trading$13.14 -0.02 (-0.17%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MED vs. USNA, NUS, NATR, VERU, EL, PBH, IPAR, HLF, FARM, and JVAShould you be buying Medifast stock or one of its competitors? The main competitors of Medifast include USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), Farmer Bros. (FARM), and Coffee (JVA). Medifast vs. USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Veru Estée Lauder Companies Prestige Consumer Healthcare Inter Parfums Herbalife Farmer Bros. Coffee USANA Health Sciences (NYSE:USNA) and Medifast (NYSE:MED) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, community ranking, dividends, risk, institutional ownership, profitability and valuation. Is USNA or MED more profitable? USANA Health Sciences has a net margin of 6.30% compared to Medifast's net margin of 0.35%. Company Net Margins Return on Equity Return on Assets USANA Health Sciences6.30% 10.64% 8.48% Medifast 0.35%10.64%7.57% Do institutionals & insiders hold more shares of USNA or MED? 54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 0.3% of USANA Health Sciences shares are owned by insiders. Comparatively, 2.5% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, USNA or MED? USANA Health Sciences has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Medifast has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Does the media prefer USNA or MED? In the previous week, USANA Health Sciences had 1 more articles in the media than Medifast. MarketBeat recorded 2 mentions for USANA Health Sciences and 1 mentions for Medifast. USANA Health Sciences' average media sentiment score of 0.66 beat Medifast's score of 0.12 indicating that USANA Health Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medifast 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor USNA or MED? USANA Health Sciences received 16 more outperform votes than Medifast when rated by MarketBeat users. However, 63.52% of users gave Medifast an outperform vote while only 60.36% of users gave USANA Health Sciences an outperform vote. CompanyUnderperformOutperformUSANA Health SciencesOutperform Votes39960.36% Underperform Votes26239.64% MedifastOutperform Votes38363.52% Underperform Votes22036.48% Which has higher earnings & valuation, USNA or MED? Medifast has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUSANA Health Sciences$854.50M0.56$63.79M$2.1911.64Medifast$602.46M0.24$99.42M$0.1873.09 Do analysts recommend USNA or MED? USANA Health Sciences currently has a consensus price target of $36.00, suggesting a potential upside of 41.19%. Medifast has a consensus price target of $16.50, suggesting a potential upside of 25.41%. Given USANA Health Sciences' higher possible upside, analysts plainly believe USANA Health Sciences is more favorable than Medifast.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryUSANA Health Sciences beats Medifast on 9 of the 15 factors compared between the two stocks. Remove Ads Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MED vs. The Competition Export to ExcelMetricMedifastfood preparations & kindred products IndustryStaples SectorNYSE ExchangeMarket Cap$143.91M$2.82B$16.49B$17.69BDividend YieldN/A2.55%2.87%3.79%P/E Ratio73.0918.5815.5429.96Price / Sales0.240.922.4124.26Price / Cash4.8811.1416.3917.54Price / Book0.681.816.504.13Net Income$99.42M$133.84M$731.75M$1.02B7 Day Performance-4.80%-6.97%-4.49%-8.68%1 Month Performance-7.44%-13.78%-4.96%-9.64%1 Year Performance-61.17%11.22%-4.06%-4.93% Medifast Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDMedifast3.8635 of 5 stars$13.16+0.7%$16.50+25.4%-61.7%$143.91M$602.46M73.09870USNAUSANA Health Sciences4.5273 of 5 stars$26.98-2.9%$36.00+33.4%-43.8%$510.06M$854.50M9.531,900NUSNu Skin Enterprises2.7466 of 5 stars$7.29+0.9%$6.88-5.6%-46.9%$362.23M$1.73B-2.473,700Gap DownNATRNature's Sunshine Products2.7265 of 5 stars$12.55-0.8%$19.00+51.4%-39.6%$231.97M$454.36M14.26850Short Interest ↑High Trading VolumeVERUVeru1.3544 of 5 stars$0.49-3.5%$4.33+784.2%-29.9%$71.74M$16.89M-1.89230Gap DownELEstée Lauder Companies4.7368 of 5 stars$66.01+0.9%$86.00+30.3%-60.2%$23.70B$15.18B-33.8563,000News CoveragePositive NewsGap DownPBHPrestige Consumer Healthcare4.0046 of 5 stars$86.07+1.2%$93.33+8.4%+21.8%$4.26B$1.12B20.16540Positive NewsHigh Trading VolumeIPARInter Parfums4.4636 of 5 stars$113.87-2.9%$162.80+43.0%-18.0%$3.66B$1.45B24.44530Short Interest ↓News CoveragePositive NewsHigh Trading VolumeHLFHerbalife4.5085 of 5 stars$8.66+1.1%$12.00+38.6%+4.1%$877.71M$4.99B3.4810,100Gap DownFARMFarmer Bros.4.1317 of 5 stars$2.22-1.8%$5.25+136.5%-42.7%$47.41M$344.84M-4.631,070Short Interest ↓JVACoffee1.2006 of 5 stars$3.55+9.6%N/A+143.6%$20.27M$80.33M9.1080News CoverageGap Down Remove Ads Related Companies and Tools Related Companies USNA Competitors NUS Competitors NATR Competitors VERU Competitors EL Competitors PBH Competitors IPAR Competitors HLF Competitors FARM Competitors JVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MED) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
